<code id='A5526D3045'></code><style id='A5526D3045'></style>
    • <acronym id='A5526D3045'></acronym>
      <center id='A5526D3045'><center id='A5526D3045'><tfoot id='A5526D3045'></tfoot></center><abbr id='A5526D3045'><dir id='A5526D3045'><tfoot id='A5526D3045'></tfoot><noframes id='A5526D3045'>

    • <optgroup id='A5526D3045'><strike id='A5526D3045'><sup id='A5526D3045'></sup></strike><code id='A5526D3045'></code></optgroup>
        1. <b id='A5526D3045'><label id='A5526D3045'><select id='A5526D3045'><dt id='A5526D3045'><span id='A5526D3045'></span></dt></select></label></b><u id='A5526D3045'></u>
          <i id='A5526D3045'><strike id='A5526D3045'><tt id='A5526D3045'><pre id='A5526D3045'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:1
          Priscilla Chan, left, with Shana Kelley and Gov. J.B. Pritzker of Illinois at the new CZ Biohub Chicago. Courtesy Dale Ramos/Chan Zuckerberg Initiative

          CHICAGO — At what point does inflammation, a key component of the body’s immune defense system, swerve out of control and start to drive disease?

          That’s the key question that a new research center, the Chan Zuckerberg Biohub Chicago, has been created to try to answer.

          advertisement

          The Chicago hub is the second one started by the Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife, Priscilla Chan. The first hub, based in the Bay Area, has been investigating cell biology and infectious diseases, while this new one is homing in on inflammatory processes in tissues across the body.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          J&J to buy cancer drug developer Ambrx Biopharma
          J&J to buy cancer drug developer Ambrx Biopharma

          AP/RichardDrewJohnson&JohnsonsaidMondaythatitwouldpurchaseAmbrxBiopharmafornearly$2billion,picki

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates